Royal DSM has successfully completed the acquisition of Kensey Nash, through the merger of its subsidiary Biomedical Acquisition Corporation with and into Kensey Nash.
As a result of the merger, Kensey Nash is now an indirect wholly owned subsidiary of DSM.
The acquisition will strengthen and complement DSM’s biomedical business, one of the three Emerging Business Areas of DSM.
The acquisition, for a total enterprise value of approximately $360m, positions DSM Biomedical as a profitable growth platform for DSM, the company said.
- Caffé Culture 2013, in pictures
- Tetra Pak receives DuPont Continuing Innovation Award
- Pom-Bear Zoo snacks from Intersnack
- Food > Flavours
- Food > Ingredients
- Manufacturing > Processing
- Food > New Products
- Distribution > Retail